Table 3.
Sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) of the different methods of fibrosis assessment, with optimal cutoffs based on histological findings*
| Cutoff Se (%) Sp (%) PPV (%) NPV (%) | |||
|---|---|---|---|
| Metavir fibrosis stage ≥ F2 | |||
| APRI | 1.00 | 55 50 | 69 29 |
| FIB-4 | 0.8 | 74 60 | 83 52 |
| FT | 0.37 | 77 80 | 88 56 |
| FM | 0.35 | 80 70 | 87 59 |
| FS | 7.3 | 75 85 | 90 55 |
| Metavir fibrosis stage ≥ F4 | |||
| APRI | 1.2 | 50 51 | 23 75 |
| FIB-4 | 1.05 | 92 70 | 46 94 |
| FT | 0.5 | 83 77 | 50 94 |
| FM | 0.68 | 83 84 | 58 94 |
| FS | 11 | 71 88 | 71 88 |
APRI = aspartate transaminase to platelet ratio index; FT = Fibrotest; FM = Fibrometer; FS = Fibroscan.